Skip to main content

Table 1 Absolute numbers and proportions of the different pneumococcal serotypes, according to they were included or not in the 23-valent polysaccharide pneumococcal vaccine (PPV) identified among case patients (n = 53).

From: Effectiveness of the 23-valent polysaccharide pneumococcal vaccine against invasive pneumococcal disease in people 60 years or older

S. pneumonia serotype

N (%)

Serotypes included in 23-valent PPV

 

   1

6 (11.3)

   3

7 (13.2)

   4

3 (5.6)

   5

2 (3.8)

   6B

3 (5.6)

   7F

3 (5.6)

   8

4 (7.5)

   9V

2 (3.8)

   12F

1 (1.9)

   14

8 (15.1)

   15B

1 (1.9)

   19A

2 (3.8)

   19F

2 (3.8)

Vaccine-related serotypes

 

   6A

2 (3.8)

   23A

2 (3.8)

Non-vaccine serotypes

 

   13

1 (1.9)

   16

1 (1.9)

   31

2 (3.8)

   38

1 (1.9)